The present invention provides compounds that are inhibitors of protein kinase, particularly inhibitors of ERK2, GSK3, PKA, CDK2 protein kinases, mammalian protein kinases involved in proliferative and neurodegenerative disorders. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of utilizing those compositions in the treatment of various disorders.
                            本发明提供了一些蛋白激酶
抑制剂,特别是ERK2、GSK3、PKA、CDK2蛋白激酶的
抑制剂,这些哺乳动物蛋白激酶与增生性和神经退行性疾病有关。本发明还提供了包括本发明中的化合物的制药组合物,并利用这些组合物治疗各种疾病的方法。